Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Panbela Therapeutics Inc (NQ: PBLA ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Panbela Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024 May 15, 2024 PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac May 06, 2024 Developed in collaboration with Sanofi. From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024 May 01, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Recap: Panbela Therapeutics Q4 Earnings March 26, 2024 Via Benzinga Earnings Preview: Panbela Therapeutics March 25, 2024 Via Benzinga Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week April 30, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 April 22, 2024 Trial's lower-than-expected event rate suggests improved survival outcomes From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Announces Poster Presentation at American Association for Cancer Research: April 18, 2024 Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Announces Transfer to OTCQB Market April 16, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023 March 26, 2024 PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024 March 12, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Top 4 Health Care Stocks That Are Preparing To Pump This Month February 23, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements February 15, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering February 01, 2024 Via Investor Brand Network Panbela Announces Closing of Approximately $9.0 Million Public Offering February 01, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire What's Going On With Panbela Therapeutics Stock Today? January 30, 2024 Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds. Via Benzinga Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR) January 30, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher January 29, 2024 U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 29, 2024 Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 29, 2024 Via Benzinga Dow Edges Lower; Cardlytics Shares Jump January 29, 2024 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P... Via Benzinga Topics Stocks Exposures US Equities US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal January 29, 2024 U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday. Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities Why Is Aclarion (ACON) Stock Down 16% Today? January 29, 2024 Aclarion stock is falling on Monday after the company issued 500,000 shares of ACON to cover principal and accrued interest from notes. Via InvestorPlace Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? January 29, 2024 Panbela Therapeutics stock is falling on Monday after pricing a public offering for PBLA shares well below its price closing price. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session January 29, 2024 Via Benzinga Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket January 29, 2024 ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 29, 2024 It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Panbela Announces Pricing of Approximately $9.0 Million Public Offering January 29, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session January 26, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.